Structural characterization of two copper(II) complexes with oxime-type ligands

Two new linear Cu^II complexes [Cu(L¹)₂] (I) (HL¹ = (E)-3,5-dichloro-2-hydroxy benzaldehyde O-methyl oxime) and [Cu(L²)₂] (II) (HL² = (E)-3,5-dichloro-2-hydroxy benzaldehyde O-ethyl oxime) are synthesized and characterized by elemental analysis, IR, UV-Vis, and X-ray diffraction methods. X-ray crystallographic analyses indicate that complexes I and II have a similar structure consisting of one Cu^II ion and two L⁻ units. In the complexes, the Cu^II ion lying on an inversion centre is four-coordinated in a trans-CuN₂O₂ square planar geometry by two phenolate O and two oxime N atoms from two symmetry-related N,O-bidentate oxime-type ligands. However, the crystal structure of the two complexes is different: complex I forms an infinite three-dimensional supramolecular network structure through intermolecular hydrogen bonding and π...π interaction, while complex II forms an infinite one-dimensional supramolecular structure through intermolecular hydrogen bonds.     

Complexes of Co(II) and Zn(II) with N-(Thio)phosphorylthioureas AdNHC(S)NHP(O)(OiPr)2 and MeNHC(S)NHP(S)(OiPr)2

The reaction of the potassium salt of the N-(thio)phosphorylated thioureas AdNHC(S)NHP(O)(OiPr)₂ (HL^I , Ad = Adamantyl) and MeNHC(S)NHP(S)(OiPr)₂ (HL^II ) with Co(II) and Zn(II) in aqueous EtOH leads to [ML^I,II ₂] chelate complexes. They were investigated by UV-vis, ¹H and ³¹P NMR spectroscopy, and microanalysis. The molecular structures of [ML^I ₂] were elucidated by single crystal X-ray diffraction analysis. The metal centers in both complexes are found to be in a distorted-tetrahedral O₂S₂ environment formed by the C=S sulfur atoms and the P=O oxygen atoms of two deprotonated L^I ligands. The photoluminescence properties of [ZnL^II ₂] are also reported.     

Co(II), Ni(II), and Cu(II) Complexation with Isatin Aminoguanisone and Nitroaminoguanisone

New complexes of bivalent Co, Ni, and Cu with isatin aminoguanisone (HL) and nitroaminoguanisone (HL¹) of the composition ([Co(HL)₂]Cl₂ (I), [Ni(HL)₂]Cl₂ (II), [Cu(L)Cl] (III), [Co(L¹)₂] (IV), [Ni(L¹)₂] (V), and [Cu(L¹)₂] (VI) are synthesized. Their molecular conductivities and effective magnetic moments are measured and thermal stabilities are studied. The type of the ligand coordination in I–VI is proposed on the basis of IR data. The summary of physicochemical data for I–VI and the energy calculations for their molecules by the molecular mechanics method made it possible to establish stoichiometry of the coordination polyhedra of the complexes.     

Antitumor activity of manganese(II) and cobalt(III) complexes of 2-acetylpyridine schiff bases derived from S-methyldithiocarbazate: Synthesis,characterization, and crystal structure of the manganese(II) complex of 2-acetylpyridine S-methyldithiocarbazate

Transition metal complexes [Mn(L)₂] (I) and [Co(L)₂] · (ClO₄) · H₂O (II), where HL = 2-acetylpyridine S-methyldithiocarbazate, have been synthesized. Complex I was characterized by elemental analysis, IR spectra, and single-crystal X-ray diffraction studies. The manganese(II) atom in complex I adopts a distorted octahedral geometry with the Schiff base coordinated to it as a uninegatively charged tridentate chelating agent via the pyridine and azomethine nitrogen atoms and the thiolate sulfur atom. Biological studies carried out in vitro against K562 leukemia cancer cell line have shown that the free ligand and its metal complexes exhibited significant and different antitumor activity, since they exhibit IC₅₀ values in the μM range.     

Biological activity of Co(III) and Ni(II) complexes of pyridine-2-carbaldehyde N(4)-methylthiosemicarbazone: Synthesis, characterization, crystal structure of Co(III) complex of pyridine-2-carbaldehyde N(4)-methylthiosemicarbazone1

Transition metal complexes formulated as [Co(L)₂]ClO₄ (I) and [Ni(L)₂] · H₂O (II), where HL = pyridine-2-carbaldehyde N(4)-methylthiosemicarbazone, have been synthesized. Complex I was characterized by elemental analysis, IR, MS and single-crystal X-ray diffraction studies. In complex I, the ligand is N₂S tridentate, coordinating to the metal center through pyridine nitrogen, imine nitrogen and sulfur atoms. Hydrogen bonds link the different components to stabilize the crystal structure. Preliminary in vitro screening indicated that the free ligand was active against various bacteria and fungi and all the tested compounds showed significant antitumor activity against K562 leukaemia cell line, and can therefore be candidates for further stages of screening in vitro and/or in vivo.     

Copper(II) Complexes with Ethyl [(Pyrazolo-1-carbothioyl)-amino]acetate Derivatives: Synthesis and Structure

Optically active derivative of the natural monoterpene (+)-3-carene, namely, ethyl (3bS,4aR)-[(3,4,4-trimethyl-3b,4,4a,5-tetrahydrocyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-carbothioyl)-amino]acetate (HL¹) and ethyl [(3,5-dimethyl-pyrazole-1-carbothioyl)-amino]acetate (HL²) were synthesized. Paramagnetic complexes [CuL¹Cl] _n (I) and [Cu₂L² ₂Cl₂] (II) were prepared. According to X-ray diffraction data, complex Iwith anion of (+)-3-carene derivative has chain structure, whereas complex IIwith anion of HL², which has no carbocyclic fragments, is a pseudodimer. Organic anions act as tetradentate bridging, cyclic ligands forming five-membered CuN₃C and CuNOC₂metal cycles. Coordination polyhedron of Cu(ClN₂O + S) in complexes Iand IIis a square pyramid. The values of _efffor complexes Iand II(1.88 and 1.84 _B, respectively) are constant in the temperature interval 78–300 K, which means that the unpaired electrons of Cu(II) ions do not exhibit any noticeable exchange interactions.     

Coordination compounds of some d metals with anthrapyridinedione derivatives: Crystal structure of 2-phenyl-4-(piperidyl-1)-anthra[1,2-b]pyridine-7,12-dionium hexabromodicuprate(II) (HL1)2[Cu2Br6]

Complexes of copper(II), nickel(II), and cobalt(II) chlorides and bromides with 2-phenyl-4-(piperidyl-1)-anthra[1,2-b]pyridine-7,12-dione (L¹) and 2-[phenyl-4-(octylamino)-anthra[1,2-b]pyridine-7,12-dione (L²) were synthesized from neutral and acidic media. The molecular and crystal structure of 2-phenyl-4-(piperidyl-1)-anthra[1,2-b]pyridine-7,12-dionium hexabromodicuprate(II) (HL¹)₂[Cu₂Br₆] was determined by X-ray diffraction analysis. The spectral characteristics of L¹ and L² and their complexes are presented. Formation of their complexes in solutions was studied.     

Redox-active antifungal cobalt(II) and copper(II) complexes with sterically hindered o-aminophenol derivatives

Co(II) complexes with 4,6-di(tert-butyl)-2-aminophenol (HL^I) and 2-anilino-4,6-di(tert-butyl)phenol (HL^II) have been synthesized and characterized by means of physico-chemical methods. The compounds HL^I and HL^II coordinate in their singly deprotonated forms and behave as bidentate O,N-coordinated ligands; their low-spin Co(II) complexes are characterized by CoN₂O₂ coordination modes and square planar geometry. Both the free ligands and their Co(II) and Cu(II) complexes (we have produced and characterized the latter before) exhibit a pronounced antifungal activity against Aspergillus niger, Fusarium spp., Mucor spp., Penicillium lividum, Botrytis cinerea, Alternaria alternata, Sclerotinia sclerotiorum, Monilia spp., which in a number of cases is comparable with that of Nystatin and Terbinafine or even higher. The reducing properties of the ligands and their metal(II) complexes, as well as their antifungal activities, were found to decrease in the order: Cu(L^I)₂ > Cu(L^II)₂ ? Co(L^I)₂ > Co(L^II)₂ > HL^I > HL^II.     

Microwave-assisted synthesis,crystal structures,and in vitro antibacterial studies of zinc(II) and nickel(II) complexes with Schiff bases

The syntheses of a mononuclear zinc(II) complex [ZnCl(L¹)(Amp)] (I) and a mononuclear nickel(II) complex [Ni(L²)(HL²)](BF₄) · 0.5H₂O (II) (HL¹ = 4-methyl-2-[(4-methylpyridin-2-ylimino) methyl]phenol, HL² = 4-methyl-2-[(pyridin-2-ylmethylimino)methyl]phenol; Amp = 2-amino-4- methylpyridine) were prepared under microwave irradiation. The complexes were characterized by a combination of elemental analyses, and IR and electronic spectra. Their structures were further confirmed by single crystal X-ray crystallography (СIF files CCDC nos 1437737 (I), 1437738 (II)). The Zn atom in the monomeric complex I is in tetrahedral coordination. The Ni atoms in the dimeric complex II are in octahedral coordination. Crystals of the complexes are stabilized by hydrogen bonds. In order to evaluate the biological activity of the complexes, in vitro antibacterial against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, and Pseudomonas aeruginosa was assayed. The complexes have strong activity against Bacillus subtilis.     

Redox-active metal(II) complexes of sterically hindered phenolic ligands: Antibacterial activity and reduction of cytochrome c. Part II. Metal(II) complexes of o-diphenol derivatives of thioglycolic acid

The synthesis and physico-chemical characterization of Fe(II) and Mn(II) complexes of 2-[4,6-di(tert-butyl)-2,3-dihydroxyphenylsulfanyl]acetic acid (HL^I) and 2-[4,6-di(tert-butyl)-2,3-dihydroxyphenylsulfinyl]acetic acid (HL^II) were carried out. The investigation of the molecular and electronic structure of Cu(II), Ni(II), Zn(II), Fe(II) and Mn(II) complexes has been performed within the density functional theory (DFT) framework. The computed properties were compared to the experimental ones, and molecular structures of the compounds were proposed based on the array of spectral data and quantum chemical calculations. Antibacterial activity of the Fe(II) and Mn(II) complexes was evaluated in comparison with Cu(II), Co(II), Ni(II) and Zn(II) complexes and three standard antibiotics; it was found to follow the order: (1) Сu(L^I)₂ > Mn(L^I)₂ > HL^I > Ni(L^I)₂ > Zn(L^I)₂ > Fe(L^I)₂ > Co(H₂O)₂L^I; (2) Cu(L^II)₂ > Сo(L^II)₂ > Ni(L^II)₂ > Mn(H₂O)₂(L^II)₂ > Fe(L^II)₂ > HL^II > Zn(L^II)₂; their reducing ability (determined electrochemically) followed the same order. Spectrophotometric investigation was carried out in order to estimate the rate of the reduction of bovine heart сytochrome c with the ligands and their metal(II) complexes. The complexes Сu(L^I)₂, Mn(L^I)₂ and Co(L^II)₂ with the high reducing ability were found to be characterized by the highest rates of Cyt с reduction. NADPH:cytochrome P450-reductase had no substantial effect on the rate of сytochrome c reduction with HL^I and HL^II ligands.     

Synthesis of Pd(II) complexes containing the protonated form or molecule of 2-(3,5-dimethylpyrazol-1-yl)-4-methylquinoline (L). The crystal structure of [Pd(HL)Cl<Subscript>3</Subscript>]

The diamagnetic complexes [Pd(HL)Cl₃](I) and PdLCl₂(II), where L is 2-(3,5-dimethylpyrazol-1-yl)-4-methylquinoline, were obtained. According to X-ray diffraction data, the crystal structure of complex I consists of mononuclear acentric molecules. The coordination polygon PdNCl₃ is a distorted square (trapezium) made up of the pyrazole N atom of the monodentate ligand (cation HL⁺) and three Cl atoms. Complex II seems to contain the square polygon PdN₂Cl₂.     

Organic acid effect on the structures of Cd(II) metal-organic complexes based on 2-(3-pyridyl)imidazo[4,5-<Emphasis Type="Italic">f</Emphasis>]-1,10-phenanthroline

Three new Cd(II) complexes consisting of phenanthroline derivative and organic acid ligands, formulated as [Cd₃(3-PIP)₂(L¹)₆] (I), [Cd(3-PIP)(L²)] · H₂O (II), and [Cd(3-PIP)(L³)] (III) (3-PIP = 2-(3-pyridyl)imidazo[4,5-f]-1,10-phenanthroline, HL¹ = 3,5-dinitrobenzoic acid, H₂L² = oxalic acid, H₂L³ = benzene-1,3-dicarboxylic acid), have been synthesized via the hydrothermal reaction and characterized by single-crystal X-ray diffraction, elemental analyses and FT-IR spectra. Complex I is a trinuclear structure. Complex II features a 1D zigzag chain. Complex III shows a twisted double chain of binuclear units sustained by double carboxylate bridges. Three complexes are further extended into 3D supramolecular frameworks by hydrogen bonding and π-π-stacking interactions. The structural differences among I–III show that the organic carboxylates have important effects on the structures. Furthermore, the supramolecular interactions are the critical factors in determining the final structures of the complexes. In addition, the thermal stabilities and luminescent properties of complexes I and II are also investigated.     

Nickel(II) and copper(II) complexes of unsymmetrical tetradentate reduced Schiff base ligands

Two new reduced Schiff base ligands, [HL¹ = 4-{2-[(pyridin-2-ylmethyl)-amino]-ethylimino}-pentan-2-one and HL² = 4-[2-(1-pyridin-2-yl-ethylamino)-ethylimino]-pentan-2-one] have been prepared by reduction of the corresponding tetradentate unsymmetrical Schiff bases derived from 1:1: 1 condensation of 1,2-ethanediamine, acetylacetone and pyridine-2-carboxaldehyde/2-acetyl pyridine. Four complexes, [Ni(L¹)]ClO₄ (1), [Cu(L¹)]ClO₄ (2), [Ni(L²)]ClO₄ (3), and [Cu(L²)]ClO₄ (4) with these two reduced Schiff base ligands have been synthesized and structurally characterized by X-ray crystallography. The mono-negative ligands L¹ and L² are chelated in all four complexes through the four donor atoms to form square planar nickel(II) and copper(II) complexes. Structures of 3 and 4 reveal that enantiomeric pairs are crystallized together with opposite chirality in the nitrogen and carbon atoms. The two Cu^II complexes (2 and 4) exhibit both irreversible reductive (Cu^II/Cu^I; E_pc, −1.00 and −1.04 V) and oxidative (Cu^II/Cu^III; E_pa, +1.22 and +1.17 V, respectively) responses in cyclic voltammetry. The electrochemically generated Cu^I species for both the complexes are unstable and undergo disproportionation.     

Synthesis,crystal structures,and catalytic properties of two oxidovanadium(V) complexes with tridentate Schiff bases

Two new oxidovanadium(V) complexes, [VO₂L¹] (I) and [VO₂L²] (II), where L¹ and L² are the deprotonated forms of 4-methyl-2-[(2-morpholin-4-ylethylimino)methyl]phenol (HL¹) and 2-[(2-isopropylaminoethylimino) methyl]-4-trifluoromethoxyphenol (HL²), respectively, have been prepared and characterized by physico chemical methods and single crystal X-ray diffraction (CIF files CCDC nos. 1443671 (I), 1443672 (II)). The V atom in each complex is coordinated by the phenolate oxygen, imino nitrogen and amino nitrogen of the Schiff base ligand, and two oxo groups, forming trigonal-bipyramidal geometry. The oxidation of olefins with the complexes as catalyst was evaluated, which indicated that both complexes showed effective catalytic efficiency in oxidation of several aliphatic and aromatic substrates by using tert-butyl hydrogen peroxide as oxidant.     

Synthesis, characterization, and X-ray crystal structures of copper(II) and nickel(II) complexes with Schiff base

New copper(II) complexes, [Cu₂L¹L²] · ClO₄ (I) and [Ni(L³)₂] (II), where L¹ is the monoanionic form of 2-[1-(2-emthylaminoethylimino)ethyl]phenol, L² is the dianionic form of N,N′-ethylene-bis(2-hydroxyacetophenonylideneimine), L³ is the mono-anionic form of 2-(1-iminoethyl)phenol, were prepared and characterized using elemental analysis, FT-IR spectroscopy, and X-ray single-crystal diffraction. In complex I, the Cu(1) atom is coordinated by the NNO tridentate ligand L¹ and the two phenolate O atoms of L², forming a square pyramidal geometry. The Cu(2) atom in complex I is coordinated by the NNOO tetradenate ligand L², forming a square planar geometry. The Ni atom in complex II is coordinated by two phenolate O and two imine N atoms from two ligands L³, forming a square planar geometry. In the crystal structure of I, the perchlorate anions are linked to the dinuclear copper(II) complex cations through intermolecular N-H...O hydrogen bonds. In the crystal structure of II, the mononuclear nickel complex molecules are linked through intermolecular N-H...O hydrogen bonds, forming a trimer.     

Synthesis and Structure of Copper(II) Complexes with Methyl [(Pyrazolo-1-carbothioyl)-amino]propionate Derivatives

Methyl 3-[(3,5-dimethylpyrazole-1-carbothioyl)-amino]propionate (L¹) and the optically active derivative of natural monoterpene (+)-3-carene, (3bS,4aR)-3-[(3,4,4-trimethyl-3b,4,4a,5-tetrahydro-cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-carbothioyl)-amino]propionate (L²), are synthesized. The paramagnetic CuL¹Cl₂ (I) and [Cu₂L² ₂Cl₄] (II) complexes are obtained. According to the X-ray diffraction data, in mononuclear complex I, the L¹ molecule performs a bidentate-cyclic function due to the coordination of the S atom of the C=S group and the N atom of the pyrazole cycle. The CuCl₂NS coordination polyhedron is a distorted tetrahedron. Two molecules of complex I form an associate due to weak Cu···S interactions. Compound II is binuclear due to the bridging function of two Cl^- ions, and analogous functions of the L¹ and L² ligands. The coordination polyhedron in complex II is CuCl₃NS. The _eff values for compounds I and II are equal to 1.81 and 1.79 _B, respectively, and are constant in the interval from 78 to 300 K, indicating that noticeable exchange interactions between unpaired electrons of the Cu²⁺ ions are absent. The EPR spectra of the complexes in the solid phase are examined.     

Redox-active metal(II) complexes of sterically hindered phenolic ligands: Antibacterial activity and reduction of cytochrome c

The synthesis and physico-chemical characterization of Fe(II) and Mn(II) complexes of 4,6-di-tert-butyl-3[(2-hydroxyethyl)sulphanyl]-1,2-dihydroxybenzene (HL^I) and 2-amino-4,6-di-tert-butylphenol (HL^II) were carried out. Antibacterial activity of the Co(II), Fe(II) and Mn(II) complexes was evaluated in comparison with Cu(II) complexes and three common antibiotics; it was found to follow the order: (1) Сu(L^I)₂ > Сo(L^I)₂ > Fe(L^I)₂ ? Mn(L^I)₂ > HL^I; (2) Сu(L^II)₂ > Сo(L^II)₂ > HL^II > Fe(L^II)₂ ? Mn(L^II)₂; and their reducing ability (determined electrochemically) followed the same order. Spectrophotometric investigation was carried out in order to estimate the rate of the reduction of bovine heart сytochrome c with the ligands and their metal(II) complexes. NADPH:cytochrome P450-reductase was found to increase the rate of сytochrome c reduction with HL^I and HL^II ligands, while adrenodoxin in couple with NAD(P)H: adrenodoxin reductase had no substantial effect thereon. It was shown that the reduction of сytochrome c with these compounds cannot be related solely to the facility of their oxidation оr ionization.     

Copper(II) complexes of N(4)-substituted thiosemicarbazones derived from pyridine-2-carbaldehyde: Crystal structure of a binuclear complex

Ten copper(II) complexes {[CuL¹Cl] (1), [CuL¹NO₃]₂ (2), [CuL¹N₃]₂ · 2/3H₂O (3), [CuL¹]₂(ClO₄)₂ · 2H₂O (4), [CuL²Cl]₂ (5), [CuL²N₃] (6), [Cu(HL²)SO₄]₂ · 4H₂O (7), [Cu(HL²)₂] (ClO₄)₂ · 1/2EtOH (8), [CuL³Cl]₂ (9), [CuL³NCS] · 1/2H₂O (10)} of three NNS donor thiosemicarbazone ligands {pyridine-2-carbaldehyde-N(4)-p-methoxyphenyl thiosemicarbazone [HL¹], pyridine-2-carbaldehyde-N(4)-2-phenethyl thiosemicarbazone [HL²] and pyridine-2-carbaldehyde N(4)-(methyl), N(4)-(phenyl) thiosemicarbazone [HL³]} were synthesized and physico-chemically characterized. The crystal structure of compound 9 has been determined by X-ray diffraction studies and is found that the dimer consists of two square pyramidal Cu(II) centers linked by two chlorine atoms.     

Crystal structures and enhanced luminescence of Zn(II) and Cd(II) complexes containing conjugated organic ligands

By self-assembly of delocalized organic ligands (L¹ and L²) with Cd(SCN)₂, ZnI₂ and Zn(NCS)₂, three luminescent complexes ZnI₂(L¹)₂ (I), [Cd(L¹)₂(μ_1,3-SCN)₂] _n (II) and Zn(NCS)₂(L²)₂ (III) were obtained (L¹ = 2-{5,5-dimethyl-3-[2-(pyridine-4-yl)ethenyl]cyclohex-2-enylidene}propanedinitrile and L² = 2-{5,5-dimethyl-3-[2-(pyridine-3-yl)ethenyl]cyclohex-2-enylidene}propanedinitrile). The structures of the complexes were determined by single crystal X-ray diffraction analysis (CIF files CCDC nos. 1406116 (I), 1406115 (II), and 1400360 (III)). In complex I, Zn(II) is coordinated by two functional organic ligands and two I^– ions, to form a I₂N₂ distorted tetrahedral geometry. In 1D coordination polymer II, the Cd(II) centers show six-coordinated geometries, two organic ligands and four SCN^– ions involve in coordination with each Cd(II) center. The thiocyanate groups show μ_1,3-SCN bridging coordination modes and the adjacent Cd(II) ions are bridged by double μ_1,3-SCN ions to form an infinite chain. In complex III, Zn(II) is coordinated by two functional organic ligands and two NCS^– groups, to form a N₄ distorted tetrahedral geometry. Compared with the free ligands, the complexes show superior luminescent property with red-shift and enhancement of fluorescence intensity.     

Copper(I) and copper(II) complexes with pyrazine-containing pyridylalkylamide ligands N-(pyridin-2-ylmethyl)pyrazine-2-carboxamide and N-(2-(pyridin-2-yl)ethyl)pyrazine-2-carboxamide

Four copper(II) complexes and one copper(I) complex with pyridine-containing pyridylalkylamide ligands N-(pyridin-2-ylmethyl)pyrazine-2-carboxamide (HL^pz) and N-(2-(pyridin-2-yl)ethyl)pyrazine-2-carboxamide (HL^pz?) were synthesized and characterized. The X-ray crystal structures of [Cu₂(L^pz)₂(4,4?-bipy)(OTf)₂] (1, OTf?=?trifluoromethanesulfonate, 4,4?-bipy?=?4,4?-bipyridine) and [Cu(L^pz)(py)₂]OTf·H₂O (2, py?=?pyridine) revealed binuclear and mononuclear molecular species, respectively, while [Cu(L^pz)(μ₂-1,1-N₃)]_n (3), [Cu(L^pz?)(μ₂-1,3-N₃)]_n (4), and [Cu(HL^pz)Cl]_n (5) are coordination polymer 1-D chains in the solid state.